Patron Exim (543798)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹8.35 |
| Market Cap | ₹20.32 Cr |
| P/E Ratio | 15.39 |
| ROCE | 0.28% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 103.57% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹1.42 — ₹9.92 |
| Sector | Chemicals & Petrochemicals |
Strengths
- P/E of 15.39 is modest for a micro-cap, not pricing in extreme optimism.
- Piotroski F-Score of 6/9 suggests reasonable recent financial health on basic metrics.
- Profit growth of 103.57% and PEG of 0.15 show reported earnings momentum, if sustainable.
- Latest quarter sales of ₹24 crore indicate the company has some trading scale relative to its ₹20 crore market cap.
Concerns
- ROCE of 0.28% is almost nil, implying no economic moat or pricing power.
- Sales growth is 0.00% and latest quarter net profit is ₹0 crore, so reported profit growth lacks operating support.
- Promoter holding, book value, debt/equity and FairStock Score are unavailable, making transparency and balance sheet risk impossible to assess.
- Zero dividend yield offers no return to shareholders while waiting for value creation.
AI Analysis
Let me apply the same filter I would to any business. Patron Exim is a chemicals trader with a market capitalization of just ₹20 crore and a share price of ₹8.35. That makes it a micro-cap, and in micro-caps the first question is always about the owner. Here, promoter holding is not available. Book value and debt-equity are also missing. Graham would say: if I cannot see the balance sheet and ownership clearly, I have no margin of safety. The operating picture is no better. Latest quarter sales were ₹24 crore, but net profit is rounded to ₹0 crore. Full-year profit growth of 103.57% looks exciting, but with sales growth of 0.00%, that profit jump is not coming from sustainable top-line expansion. Return on capital employed is only 0.28%, so the company generates almost no economic return on the money it uses. A trader in chemicals lacks pricing power and a moat; any prosperity depends on spreads, credit and volume, all of which can reverse. The P/E of 15.39 is not high, but it is meaningless if current earnings are weak. The PEG of 0.15 is a mathematical curiosity, not an investment signal, because it assumes the 103% growth is durable. The 52-week range, from ₹1.42 to ₹9.92, tells me this stock is speculative. The Piotroski score of 6/9 is modestly healthy, but that is not enough. I am not interested in buying a ticket on a volatile trader. I need evidence of durable earning power, transparency and honest capital allocation. Patron Exim does not meet that standard today. I will watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer